For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

Lactation triggers significant metabolic changes in mothers, driven by shifting hormone levels and brain activity.

Nursing poses major metabolic demands on mothers, to which they respond by eating more and saving energy to sustain milk production. There are significant hormonal changes during lactation, but how ...

The U.S. obesity rate is about 40%, according to a 2021-2023 survey of about 6,000 people. Nearly 1 in 10 of those surveyed ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

With the global prevalence of obesity on the rise, it is crucial to explore the neural mechanisms linked to obesity and its influence on brain and cognitive health. However, the impact of obesity on ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an ...

Prenatal sex steroid hormones were associated with infant growth trajectories, adiposity, and birth weight in a sex-dependent manner.

Some of these changes happen as a natural part of aging, while others are related to shifts in sex hormones during the ...